Lithium Carbonate Tablet, Extended Release
Product Images NDC 46708-148

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 46708-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

30's Bottle Pack (Lithium 300mg)

30's Bottle Pack (Lithium 300mg)
Each tablet contains Lithium Carbonate USP 200mg. This medication comes in extended-release tablets and is used as a mood stabilizer to treat bipolar disorder. The usual dosage instructions can be found in the accompanying insert. This medication should be stored in a tightly sealed and child-resistant container at a controlled room temperature of 20°C to 25°C (68°F to 77°F). This medication is manufactured by Aembic Pharmaceuticals Limited, a formulation division, located in Gujarat, India. It is important to protect the medication from moisture and flames. The NDC number for this medication is 46708-148-30 and it is available in 30 tablet size. The label also displays a batch and an expiration date. This medication requires a prescription from a doctor or other licensed healthcare provider.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.